David Shaw’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-45,000
Closed -$160K – 4536
2025
Q4
$160K Buy
+45,000
New +$276K ﹤0.01% 4358

Other funds holding AVXL

David Shaw's AVXL Position: Q3 2026 in Review

David Shaw increased its Anavex Life Sciences (AVXL) stake by 66% in Q3 2026, buying an estimated $211K and bringing the position to 191,638 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #4380.

David Shaw first reported a position in AVXL in Q2 2016 and has held it in 24 quarters since. The position peaked at $3.81M in Q1 2022. 167 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • David Shaw held 191,638 shares of Anavex Life Sciences worth $387K as of Q3 2026.
  • David Shaw bought 76,176 Anavex Life Sciences shares in Q3 2026, an estimated $211K.
  • Anavex Life Sciences made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4380 holding.
  • David Shaw first reported a position in Anavex Life Sciences in Q2 2016 and has held it in 24 quarters since.
  • David Shaw's Anavex Life Sciences position peaked at $3.81M in Q1 2022.
  • 167 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.